Abstract | UNLABELLED: Seroprevalence studies in adults done in San Juan and Puerto Rico have showed 6.3% and 2.2% of the population respectively, are positive for antibodies to Hepatitis C Virus (anti-HCV). It is been suggested that Hispanics have a lower sustained virological response to current therapy. The epidemiologic profile, the response to treatment and the risk factors to the poor response to treatment of HCV patients have not been studied in the southern area of Puerto Rico. METHODS: This is a cross-sectional analysis of data from 46 medical records from January 2005 to March 2011. We search for sociodemographic variables, comorbidities, the HCV genotype, the human immunodeficiency virus profile, history of alcoholism and the patients who were treated with peginterferon alpha 2b and ribavirin, and their response to treatment. RESULTS: DISCUSSION: Overall, our population showed an epidemiological profile similar to other Hispanic groups in the literature, which should motivate us to continue exploring these associations, in an effort to improve the management of these patients.
|
Authors | David Colón-Ruiz, Bárbara Rosado Carrión, Rafael Bredy |
Journal | Boletin de la Asociacion Medica de Puerto Rico
(Bol Asoc Med P R)
2012 Apr-Jun
Vol. 104
Issue 2
Pg. 42-7
ISSN: 0004-4849 [Print] Puerto Rico |
PMID | 23882973
(Publication Type: Journal Article)
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Cross-Sectional Studies
- Female
- Hepatitis C, Chronic
(epidemiology)
- Hispanic or Latino
- Humans
- Male
- Middle Aged
- Puerto Rico
(epidemiology)
- Time Factors
|